Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ)

NCT03786757 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

ST Segment Elevation Myocardial Infarction
Left Ventricular Thrombus

Interventions

DRUG: Rivaroxaban

Sponsor

RenJi Hospital